Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for high-single-digit growth by 2027.

Creative Diagnostics, a global provider of reagents and analytical services, has released its innovative Gene Copy Number ...

The research team designed an innovative diagnostic kit by utilizing the principle of water and oil layering to detect bladder cancer biomarkers. Biomarker detection in urine has been challenging ...

By seamlessly combining a variety of molecular technologies, diagnostic kit manufacturing, comprehensive bioinformatics and regulatory support, Bio-Techne is an ideal partner for biopharmaceutical ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

Shares of Asian diagnostic kit makers and vaccine producers rallied on Monday, following global peers higher after researchers discovered a new coronavirus in bats that enters cells using the same ...

Agilent Technologies Inc. (NYSE: A) has announced that its PD-L1 IHC 28-8 pharmDx kit has obtained two new companion diagnostic indications approvals in the European Union, enhancing treatment ...

Agilent Technologies (NYSE:A) recently achieved EU IVDR approval for two new indications of its PD-L1 IHC 28-8 pharmDx kit, expanding treatment options for early-stage NSCLC and advanced melanoma.